Exendin-4 enhances radiation response of prostate cancer

The Prostate
Wenjing He, Junhe Li

Abstract

Exendin-4, one of the most widely used antidiabetic drugs, has recently been reported to have potential antitumor effects in cancers. Prostate cancer (PC) is one of the most common cancers in male patients with type 2 diabetes mellitus, and radiotherapy plays a vital role in the therapy of PC. Whether exendin-4 has the potential to enhance PC response to ionizing radiation (IR) remains unknown. We aimed to explore whether exendin-4 radiosensitizes PC cells. GLP-1 receptor (GLP-1R) expression in PC tissue samples and cell lines were analyzed, Human prostate cancer cells (PC3 and LNCap) were treated with IR and exendin-4, and subjected to proliferation, clone formation, cell cycle, immunoblotting, and immunohistochemical analysis. An in situ prostate tumor of animal model was established. We found that GLP-1R was expressed in human PC tissues and cell lines. 1-100 nM exendin-4 promoted the anti-proliferation effects of IR in vitro and in vivo, and enhanced radiation-induced G2/M cycle arrest in PC cells in a dose-dependent manner. Furthermore, Ex-4 increased AMPK phosphorylation, decrease the levels of p-mTOR, cyclin B, and p34cdc2 . Our study suggested exendin-4 radiosensitizes PC cells via activation of AMPK A and subsequent in...Continue Reading

References

Aug 5, 2006·Annals of the New York Academy of Sciences·Patricia L Brubaker
Sep 13, 2008·Molecular and Cellular Endocrinology·Jens Juul HolstCarolyn F Deacon
Jul 10, 2010·International Journal of Radiation Oncology, Biology, Physics·Toran SanliTheodoros Tsakiridis
Jun 4, 2011·Breast Cancer Research and Treatment·Hagai LigumskyTami Rubinek
Jul 1, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Vanessa E ZannellaMarianne Koritzinsky
Sep 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Dong HanMan-Xiang Li
Dec 20, 2013·International Journal of Molecular Sciences·Ben-Dong ChenQi Wang
Apr 15, 2014·Disease-a-month : DM·Daniel M SamanMartin S Lipsky
Jun 1, 2014·Diabetes·Takashi NomiyamaToshihiko Yanase
Feb 25, 2015·The Journal of Clinical Endocrinology and Metabolism·Robert L PlewsJohn E Phay
Aug 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robert F WolffJos Kleijnen
Jul 28, 2016·Biochemical and Biophysical Research Communications·Nana LiWenyan Niu
Jul 31, 2016·Journal of Translational Medicine·Francesco AndreozziFranco Folli
Aug 9, 2016·Molecular and Cellular Endocrinology·Wenjing HeHaipeng Xiao
Oct 7, 2016·International Journal of Immunopathology and Pharmacology·Chethan Gejjalagere Honnappa, Unnikrishnan Mazhuvancherry Kesavan

❮ Previous
Next ❯

Citations

May 1, 2021·Cancers·Miłosz KnuraTomasz Francuz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.